Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 1/2020

01-01-2020 | Oral Anticoagulant | Letter to the Editor

Vitamin K Antagonist Use and Fracture

Authors: Wallis C. Y. Lau, PhD, Kenneth K. C. Man, MPH, Ian C. K. Wong, PhD

Published in: Journal of General Internal Medicine | Issue 1/2020

Login to get access

Excerpt

We read with interest the article by Fiordellisi and colleagues, who reported findings of a systematic review and meta-analysis on the association between vitamin K antagonist (VKA) use and fracture.1 The results provide an important contribution to better understand the risk of fractures associated with VKA use, which is still controversial and not well described in clinical practice. …
Literature
1.
2.
Lucenteforte E, Bettiol A, Lombardi N, Mugelli A, Vannacci A. Risk of bone fractures among users of oral anticoagulants: An administrative database cohort study. Eur J Intern Med. 2017;44:e30-e1.CrossRef
3.
Norby FL, Bengtson LGS, Lutsey PL, Chen LY, MacLehose RF, Chamberlain AM, et al. Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord. 2017;17(1).
4.
Steffel J, Giugliano RP, Braunwald E, Murphy SA, Mercuri M, Choi Y, et al. Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis. J Am Coll Cardiol. 2016;68(11):1169–78.CrossRef
5.
Lau WC, Chan EW, Cheung CL, Sing CW, Man KK, Lip GY, et al. Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation. JAMA. 2017;317(11):1151–8.CrossRef
Metadata
Title
Vitamin K Antagonist Use and Fracture
Authors
Wallis C. Y. Lau, PhD
Kenneth K. C. Man, MPH
Ian C. K. Wong, PhD
Publication date
01-01-2020
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 1/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05185-2

Other articles of this Issue 1/2020

Journal of General Internal Medicine 1/2020 Go to the issue

Editorial

Opioid Tapering and the Patient-Provider Relationship

Original Research

How Clinicians Discuss Medications During Primary Care Encounters Among Older Adults with Cognitive Impairment

From the Editors' Desk

From the Editors’ Desk: The Importance of Screening for Depression in Primary Care

Original Research

Awareness and Discussions About Chronic Kidney Disease Among African-Americans with Chronic Kidney Disease and Hypertension: a Mixed Methods Study

Original Reserch

Telemonitoring and Team-Based Management of Glycemic Control on People with Type 2 Diabetes: a Cluster-Randomized Controlled Trial

Editorial

A Provider - Patient Relationship: The Critical First Step of Smoking Cessation

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits